Skip to content

Solid Biosciences Inc. SLDB Free cash flow yield

Free cash flow yield at other companies

Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
-4%-0.9pp
Biogen logo
BiogenBIIB
9%-3.2pp
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
6.3%+1.8pp
Insmed logo
InsmedINSM
-2.6%-0.9pp
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
-14.8%-4.6pp
Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
-8.7%-3.6pp

Other financials

Income statement

See full
Revenue$2.0M-40.6%
Operating income-$57.3M-43.1%
Net income-$56.7M-44.4%
EPS (diluted)-$0.52+11.9%

Balance sheet

See full
Cash & equivalents$297.1M+41.1%
Total debt$20.7M-12.5%
Total equity$374.1M+27.1%
Total assets$422.9M+23.0%

Cash flow

See full
Operating cash flow-$47.2M-48.3%
CapEx$165.0K+31.0%
Free cash flow-$47.4M-48.2%

Valuation

See full
Market cap$910.66M+135%
Enterprise value$634.23M+223%
P/S112.5×-10.3×

Profitability

See full
Operating margin-1,315.2%-4,060pp
Net margin-1,062.3%-251,151pp
FCF margin-1,247.7%-9,569pp

Returns & leverage

See full
Return on equity-57.4%+2.2pp
Debt / equity0.1×0.0×
Current ratio13.1×+2.2×

Where this comes from

Calculated from Solid Biosciences Inc.’s reported figures.

Based on trailing twelve months.

The official record: Solid Biosciences Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Solid Biosciences Inc.'s free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Solid Biosciences Inc.'s free cash flow yield?
Solid Biosciences Inc. (SLDB) reported free cash flow yield of -24.4% in Q1 2026.
How has Solid Biosciences Inc.'s free cash flow yield changed year-over-year?
Solid Biosciences Inc.'s free cash flow yield increased by 34.8% year-over-year, from -37.4% to -24.4%.
What is the long-term trend for Solid Biosciences Inc.'s free cash flow yield?
Over 5 years (2020 to 2025), Solid Biosciences Inc.'s free cash flow yield has grown at a 38.5% compound annual growth rate (CAGR), from -7% to -35.8%.
What does free cash flow yield mean?
Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.